Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2016

01-04-2016 | Editorial

Tired of Hepatitis B?

Authors: Kavish R. Patidar, Jasmohan S. Bajaj

Published in: Digestive Diseases and Sciences | Issue 4/2016

Login to get access

Excerpt

Fatigue is a symptom complex encompassing that is often reported as malaise, exhaustion, and lethargy, with a reported prevalence of 25 % in the overall population [1]. While some fatigue is to be expected as a consequence of daily activities (i.e., exercise, work, activities of daily living), it is also an important patient-reported outcome in chronic diseases. Fatigue can be either central or peripheral (or both) in etiology [2]. Peripheral fatigue is a result of neuromuscular dysfunction, which often manifests clinically as weakness in patients with advanced liver disease, whereas central fatigue is often associated with neuropsychiatric problems (i.e., depression and anxiety) and sleep issues. Central fatigue often manifests as difficulty in performing physical and mental activities that require self-motivation and internal signals. …
Literature
1.
go back to reference Cullen W, Kearney Y, Bury G. Prevalence of fatigue in general practice. Irish J Med Sci. 2002;171:10–12.CrossRefPubMed Cullen W, Kearney Y, Bury G. Prevalence of fatigue in general practice. Irish J Med Sci. 2002;171:10–12.CrossRefPubMed
2.
3.
go back to reference Newton JL, Jones DE. Managing systemic symptoms in chronic liver disease. J Hepatol. 2012;56:S46–S55.CrossRefPubMed Newton JL, Jones DE. Managing systemic symptoms in chronic liver disease. J Hepatol. 2012;56:S46–S55.CrossRefPubMed
4.
go back to reference Marcellin F, Preau M, Ravaux I, Dellamonica P, Spire B, Carrieri MP. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials. 2007;8:320–327.CrossRefPubMed Marcellin F, Preau M, Ravaux I, Dellamonica P, Spire B, Carrieri MP. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials. 2007;8:320–327.CrossRefPubMed
5.
go back to reference Jones DEJ, Sutcliffe K, Pairman J, Wilton K, Newton JL. An integrated care pathway improves quality of life in primary biliary cirrhosis. QJM. 2008;101:535–543.CrossRefPubMed Jones DEJ, Sutcliffe K, Pairman J, Wilton K, Newton JL. An integrated care pathway improves quality of life in primary biliary cirrhosis. QJM. 2008;101:535–543.CrossRefPubMed
6.
go back to reference Negro F, Forton D, Craxi A, Sulkowski MS, Feld JJ, Manns MP. Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology. 2015;149:1345–1360.CrossRefPubMed Negro F, Forton D, Craxi A, Sulkowski MS, Feld JJ, Manns MP. Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology. 2015;149:1345–1360.CrossRefPubMed
7.
go back to reference Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, et al. Fatigue in patients with chronic hepatitis B living in North America: results from the hepatitis B research network (HBRN). Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-015-4006-0. Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, et al. Fatigue in patients with chronic hepatitis B living in North America: results from the hepatitis B research network (HBRN). Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-015-4006-0.
8.
go back to reference Rothrock NE, Hays RD, Spritzer K, Yount SE, Riley W, Cella D. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2010;63:1195–1204.CrossRefPubMedPubMedCentral Rothrock NE, Hays RD, Spritzer K, Yount SE, Riley W, Cella D. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2010;63:1195–1204.CrossRefPubMedPubMedCentral
9.
go back to reference Bajaj JS, Thacker LR, Wade JB, et al. PROMIS computerised adaptive tests are dynamic instruments to measure health- related quality of life in patients with cirrhosis. Aliment Pharmacol Ther. 2011;34:1123–1132.CrossRefPubMedPubMedCentral Bajaj JS, Thacker LR, Wade JB, et al. PROMIS computerised adaptive tests are dynamic instruments to measure health- related quality of life in patients with cirrhosis. Aliment Pharmacol Ther. 2011;34:1123–1132.CrossRefPubMedPubMedCentral
10.
go back to reference Russ TC, Kivimaki M, Morling JR, Starr JM, Stamatakis E, Batty GD. Association between psychological distress and liver disease mortality: a meta-analysis of individual study participants. Gastroenterology. 2015;148:958.e4–966.e4.CrossRef Russ TC, Kivimaki M, Morling JR, Starr JM, Stamatakis E, Batty GD. Association between psychological distress and liver disease mortality: a meta-analysis of individual study participants. Gastroenterology. 2015;148:958.e4–966.e4.CrossRef
11.
go back to reference Cordoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology. 1998;27:339–345.CrossRefPubMed Cordoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology. 1998;27:339–345.CrossRefPubMed
12.
go back to reference Kanwal F, Gralnek IM, Hays RD, et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7:793–799.CrossRefPubMed Kanwal F, Gralnek IM, Hays RD, et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7:793–799.CrossRefPubMed
Metadata
Title
Tired of Hepatitis B?
Authors
Kavish R. Patidar
Jasmohan S. Bajaj
Publication date
01-04-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4067-8

Other articles of this Issue 4/2016

Digestive Diseases and Sciences 4/2016 Go to the issue

DDS-GRG Profiles and Perspectives

GRG Profiles: George Triadafilopoulos

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.